Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules
In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that re...
Saved in:
| Published in | Philosophical transactions of the Royal Society of London. Series B. Biological sciences Vol. 367; no. 1590; pp. 800 - 811 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
The Royal Society
19.03.2012
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0962-8436 1471-2970 1471-2970 |
| DOI | 10.1098/rstb.2011.0266 |
Cover
| Abstract | In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity—combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands—drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species. |
|---|---|
| AbstractList | In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity—combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands—drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species. In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity—combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands—drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species. In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity-combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands-drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species.In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity-combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands-drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species. |
| Author | Abi-Rached, Laurent Parham, Peter Norman, Paul J. Guethlein, Lisbeth A. |
| AuthorAffiliation | 2 Department of Microbiology and Immunology , Stanford University , Stanford, CA 94305 , USA 1 Department of Structural Biology , Stanford University , Stanford, CA 94305 , USA |
| AuthorAffiliation_xml | – name: 1 Department of Structural Biology , Stanford University , Stanford, CA 94305 , USA – name: 2 Department of Microbiology and Immunology , Stanford University , Stanford, CA 94305 , USA |
| Author_xml | – sequence: 1 givenname: Peter surname: Parham fullname: Parham, Peter email: peropa@stanford.edu organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA – sequence: 2 givenname: Paul J. surname: Norman fullname: Norman, Paul J. organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA – sequence: 3 givenname: Laurent surname: Abi-Rached fullname: Abi-Rached, Laurent organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA – sequence: 4 givenname: Lisbeth A. surname: Guethlein fullname: Guethlein, Lisbeth A. organization: Department of Structural Biology, Stanford University, Stanford, CA 94305, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22312047$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUk1v1DAQjVAR_YArN1BucMnWX7GTCxKsKK1UgdQWerQcx9l617GDnSxdfgC_G4e0CwW1nPwx772ZeTP7yY51ViXJcwhmEJTFoQ99NUMAwhlAlD5K9iBhMEMlAzvJHigpygqC6W6yH8ISAFDmjDxJdhHCEAHC9pIfx0MrbBY6JXWjZarWzgy9djZ1TbrSxiifSmVMqtt2sG5hXDUYbTOjVyr1Sqqud368uIXVt7xWLOPnlQ69k67tRK8rbXS_SceXUdepNCKE9CRtnVFyMCo8TR43wgT17OY8SD4fvb-YH2ennz6czN-eZpIi2me1ErG9EmMoBEGQVYBBUsAGV0A1KM_rukaIoJpUNKcVzgEpaqRQqUglGwAJPkgOJ93BdmLzTRjDO69b4TccAj46ykdH-egoHx2NjDcToxuqVtVS2d6L3ywnNL8bsfqKL9yaY0QZhDgKvLoR8O7roELPWx1GS4VVbgi8RADTklEQka8fREIAigJFA1CEvvyzqm05t4ONgNkEkN6F4FXz_z7JXwSpezFONHalzf201UTzbhMH56RW_YYv3eBtfPKz84t3a0yZhnkJOCgwBBQDkvPvupukYpDrEAbFf0Huyv-bDT-U7d4aX0ysZVxIvzWCQEIgw-OEsikeF1Zdb-PCrzhlmOX8S0H4x6Ozy_n5HPBL_BNoixf1 |
| CitedBy_id | crossref_primary_10_1007_s00251_015_0828_3 crossref_primary_10_3390_cancers11070996 crossref_primary_10_4049_jimmunol_1900423 crossref_primary_10_1111_iji_12515 crossref_primary_10_1093_toxsci_kfz098 crossref_primary_10_3389_fimmu_2015_00268 crossref_primary_10_1016_j_humgen_2022_201086 crossref_primary_10_1084_jem_20152023 crossref_primary_10_3389_fimmu_2015_00540 crossref_primary_10_1007_s00005_015_0350_1 crossref_primary_10_3892_mco_2016_1106 crossref_primary_10_1002_mco2_626 crossref_primary_10_3389_fimmu_2021_640334 crossref_primary_10_4049_jimmunol_1401689 crossref_primary_10_3389_fimmu_2018_01345 crossref_primary_10_1016_j_bbmt_2019_10_032 crossref_primary_10_1371_journal_ppat_1010612 crossref_primary_10_3390_biom13050748 crossref_primary_10_1007_s00251_017_1038_y crossref_primary_10_1007_s00251_022_01259_4 crossref_primary_10_1146_annurev_animal_022513_114234 crossref_primary_10_4049_jimmunol_1500227 crossref_primary_10_3389_fimmu_2016_00060 crossref_primary_10_1111_tan_15177 crossref_primary_10_1007_s11427_018_9458_0 crossref_primary_10_1093_ilar_ilt043 crossref_primary_10_5500_wjt_v6_i3_532 crossref_primary_10_3389_fimmu_2023_1135148 crossref_primary_10_1007_s00262_015_1750_0 crossref_primary_10_1186_s40246_022_00429_5 crossref_primary_10_3389_fimmu_2017_00212 crossref_primary_10_1002_ajhb_23545 crossref_primary_10_4049_jimmunol_1300111 crossref_primary_10_1016_j_humimm_2018_10_003 crossref_primary_10_1016_j_critrevonc_2020_103206 crossref_primary_10_1111_jcpe_12212 crossref_primary_10_1016_j_jim_2015_07_008 crossref_primary_10_1002_rmb2_12610 crossref_primary_10_1016_j_gde_2014_08_001 crossref_primary_10_1111_imr_12325 crossref_primary_10_1182_bloodadvances_2023009827 crossref_primary_10_1016_j_humimm_2015_10_019 crossref_primary_10_4049_jimmunol_1602163 crossref_primary_10_1007_s00251_020_01161_x crossref_primary_10_3389_fgene_2021_774916 crossref_primary_10_4049_jimmunol_1300081 crossref_primary_10_1111_imr_12323 crossref_primary_10_1007_s00251_013_0752_3 crossref_primary_10_1038_srep42470 crossref_primary_10_1111_iji_12490 crossref_primary_10_4049_jimmunol_1801363 crossref_primary_10_1146_annurev_biochem_011520_102754 crossref_primary_10_7554_eLife_75670 crossref_primary_10_3389_fimmu_2017_00832 crossref_primary_10_1007_s00251_014_0778_1 crossref_primary_10_1186_s40364_024_00610_z crossref_primary_10_1038_s41571_020_0426_7 crossref_primary_10_1086_706768 crossref_primary_10_3389_fimmu_2014_00105 crossref_primary_10_1016_j_jaip_2022_04_036 crossref_primary_10_1111_imr_12316 crossref_primary_10_1016_j_humimm_2017_05_002 crossref_primary_10_3389_fimmu_2023_1308316 crossref_primary_10_1016_j_jri_2021_103425 crossref_primary_10_1371_journal_pone_0163297 crossref_primary_10_1111_tan_12523 crossref_primary_10_1111_imm_12137 crossref_primary_10_1371_journal_pbio_1002144 crossref_primary_10_1016_j_repbio_2015_08_001 crossref_primary_10_1111_tan_13971 crossref_primary_10_3389_fimmu_2022_992723 crossref_primary_10_1098_rstb_2011_0318 crossref_primary_10_3389_fmed_2023_1148748 crossref_primary_10_3390_vaccines8040677 crossref_primary_10_1111_iji_12433 crossref_primary_10_1016_j_eimc_2013_10_007 crossref_primary_10_3390_ijms23137030 crossref_primary_10_1016_j_humimm_2017_07_010 crossref_primary_10_1002_ajhb_22391 crossref_primary_10_1093_molbev_msz249 crossref_primary_10_1016_j_trim_2017_10_002 crossref_primary_10_3389_fimmu_2018_02991 crossref_primary_10_1177_0961203316638931 crossref_primary_10_1146_annurev_med_052511_135400 crossref_primary_10_1002_eji_201545757 crossref_primary_10_1111_cei_12582 crossref_primary_10_1158_0008_5472_CAN_12_3322 crossref_primary_10_1186_s12967_022_03437_0 crossref_primary_10_3389_fimmu_2024_1423149 crossref_primary_10_1101_gr_137976_112 crossref_primary_10_1371_journal_pone_0141536 crossref_primary_10_1016_j_jri_2012_10_009 crossref_primary_10_3389_fimmu_2021_755624 crossref_primary_10_1186_s12865_024_00631_1 crossref_primary_10_3390_cancers13071536 crossref_primary_10_1146_annurev_immunol_042617_053149 crossref_primary_10_1098_rstb_2014_0070 crossref_primary_10_1016_j_humimm_2018_03_010 crossref_primary_10_1016_j_placenta_2011_11_020 crossref_primary_10_1016_j_coi_2017_11_003 crossref_primary_10_1371_journal_pone_0180831 crossref_primary_10_1007_s11033_019_04900_w crossref_primary_10_1038_s41467_021_22359_x crossref_primary_10_1111_tan_12423 crossref_primary_10_1111_tan_13754 crossref_primary_10_1111_tan_13996 crossref_primary_10_1111_imm_13289 crossref_primary_10_1089_scd_2012_0402 crossref_primary_10_1002_JLB_6RI0917_390R crossref_primary_10_1016_j_xagr_2024_100321 crossref_primary_10_1073_pnas_1322052111 crossref_primary_10_1093_infdis_jiy492 crossref_primary_10_1111_ajt_12134 crossref_primary_10_4049_jimmunol_1701480 crossref_primary_10_4049_jimmunol_1100431 crossref_primary_10_1007_s00005_017_0474_6 crossref_primary_10_1155_2015_427217 crossref_primary_10_3389_fimmu_2019_00177 crossref_primary_10_4049_jimmunol_1401980 crossref_primary_10_1007_s00251_017_1017_3 crossref_primary_10_1016_j_humimm_2013_04_028 crossref_primary_10_1371_journal_pntd_0002744 crossref_primary_10_1016_j_humimm_2015_03_022 crossref_primary_10_3389_fimmu_2021_716289 crossref_primary_10_1126_sciimmunol_aag1672 crossref_primary_10_1371_journal_pone_0064936 crossref_primary_10_1007_s00251_015_0888_4 crossref_primary_10_1371_journal_pgen_1005439 crossref_primary_10_1111_tan_12299 crossref_primary_10_3389_fimmu_2023_1269614 crossref_primary_10_1111_tan_13817 crossref_primary_10_1111_tan_13939 crossref_primary_10_3389_fgene_2022_829891 crossref_primary_10_3389_fmicb_2015_01061 crossref_primary_10_1111_aji_12453 crossref_primary_10_1007_s00251_016_0918_x crossref_primary_10_1016_j_jconrel_2023_08_014 crossref_primary_10_4049_jimmunol_1901140 crossref_primary_10_1111_mec_13468 crossref_primary_10_1007_s00005_013_0225_2 crossref_primary_10_1200_JCO_2012_47_4007 crossref_primary_10_1016_j_humimm_2015_01_020 crossref_primary_10_1073_pnas_1903781116 crossref_primary_10_1155_2016_2079704 crossref_primary_10_1111_sji_12348 |
| Cites_doi | 10.4049/jimmunol.0901734 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E 10.4049/jimmunol.1000078 10.4049/jimmunol.156.9.3098 10.1093/nar/gkq1128 10.1016/j.it.2010.05.007 10.4049/jimmunol.178.1.33 10.4049/jimmunol.178.2.647 10.1146/annurev.iy.11.040193.003145 10.4049/jimmunol.0803401 10.4049/jimmunol.0803026 10.1016/j.smim.2008.06.003 10.1016/0167-5699(90)90097-S 10.1002/1521-4141(200203)32:3<810::AID-IMMU810>3.0.CO;2-P 10.1073/pnas.95.24.14326 10.1016/j.humimm.2005.11.007 10.1182/blood-2009-12-256586 10.1084/jem.20051884 10.1007/s00251-007-0214-x 10.1111/j.1365-2567.2010.03398.x 10.1073/pnas.94.12.6313 10.1126/science.1097670 10.4049/jimmunol.0903016 10.1016/j.gene.2004.03.018 10.1371/journal.pone.0015115 10.1007/s00251-006-0108-3 10.1016/j.smim.2008.09.007 10.4049/jimmunol.169.1.220 10.1182/blood-2009-07-231977 10.1016/j.placenta.2009.12.022 10.1016/S1074-7613(00)80219-8 10.4049/jimmunol.172.1.356 10.1084/jem.185.8.1523 10.1016/j.immuni.2006.06.013 10.4049/jimmunol.0902332 10.1126/science.1198687 10.1371/journal.pgen.1001249 10.1016/j.it.2011.02.003 10.4049/jimmunol.181.9.6293 10.1038/gene.2008.91 10.1007/s00251-002-0529-6 10.1186/1471-2164-7-209 10.1016/j.smim.2008.05.004 10.1172/JCI43998 10.1182/blood-2008-03-143727 10.1038/nri1570 10.1002/eji.1830270517 10.1182/blood-2008-07-171926 10.1007/s00251-008-0342-y 10.1084/jem.189.7.1093 10.1101/gr.2381205 10.3324/haematol.2009.021121 10.4049/jimmunol.161.2.571 10.1016/S0161-5890(02)00030-5 10.1007/978-3-642-48287-8 10.1002/eji.1830271203 10.1073/pnas.0906051106 10.1038/ng2035 10.1182/blood-2008-10-184549 10.1016/j.immuni.2006.03.006 10.1073/pnas.0913745107 10.1073/pnas.1003865108 10.1016/j.molimm.2010.10.014 10.4049/jimmunol.158.9.4026 10.1371/journal.pgen.1001192 10.1371/journal.pgen.1000688 10.1002/eji.200425089 10.1007/s00251-011-0535-7 10.1084/jem.180.4.1235 10.4049/jimmunol.166.7.4380 10.4049/jimmunol.169.9.5118 10.1084/jem.20041214 10.1182/blood-2004-12-4825 10.4049/jimmunol.179.1.491 10.1016/j.ygeno.2004.01.010 10.4049/jimmunol.1001494 10.1038/nature09534 10.4049/jimmunol.168.1.240 10.1084/jem.20091010 10.1093/humrep/den011 10.1084/jem.20020304 10.1056/NEJM198906293202605 10.1038/nri1897 10.1038/35869 10.1073/pnas.080588597 10.1073/pnas.94.9.4604 10.1371/journal.pgen.0010027 10.1126/science.1068440 10.1016/S1074-7613(00)80394-5 10.4049/jimmunol.1001951 |
| ContentType | Journal Article |
| Copyright | Copyright © 2012 The Royal Society This journal is © 2012 The Royal Society This journal is © 2012 The Royal Society 2012 |
| Copyright_xml | – notice: Copyright © 2012 The Royal Society – notice: This journal is © 2012 The Royal Society – notice: This journal is © 2012 The Royal Society 2012 |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 5PM ADTOC UNPAY |
| DOI | 10.1098/rstb.2011.0266 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Sciences (General) Biology |
| DocumentTitleAlternate | Review. Coevolution of KIR and HLA class I |
| EISSN | 1471-2970 |
| EndPage | 811 |
| ExternalDocumentID | 10.1098/rstb.2011.0266 PMC3267113 22312047 10_1098_rstb_2011_0266 41441733 ark_67375_V84_NFRWCSC0_W |
| Genre | Journal Article Review Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: AI17892 – fundername: NIAID NIH HHS grantid: R01 AI017892 – fundername: NIAID NIH HHS grantid: AI22039 – fundername: NIAID NIH HHS grantid: R01 AI022039 |
| GroupedDBID | --- -~X 0R~ 29O 2WC 4.4 53G AACGO AANCE ABBHK ABPLY ABTLG ABXSQ ACPRK ACQIA ACSFO ADACV ADBBV ADULT AEUPB AEXZC AFRAH AJZGM ALMA_UNASSIGNED_HOLDINGS ALMYZ AOIJS AQVQM BAWUL BGBPD BSCLL BTFSW DCCCD DIK DOOOF E3Z EBS EJD F5P GX1 H13 HYE HZ~ IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST K-O KQ8 MRS MV1 NSAHA O9- OK1 OP1 RPM RRY SA0 TN5 V1E W8F YNT ~02 ACHIC ACRPL ADNMO ADQXQ AGPVY AGQPQ ABPTK ABXXB ADZLD DNJUQ DWIUU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 5PM AANZV ABIEJ ACMKX ADTOC AS~ CAG COF HGD HQ3 HTVGU MVM ROL UNPAY WHG WOQ |
| ID | FETCH-LOGICAL-c626t-dea4719331aa4217b071481f3b0ef255ddd2242d4b656b35048d2e29e4bcf0143 |
| IEDL.DBID | UNPAY |
| ISSN | 0962-8436 1471-2970 |
| IngestDate | Sun Oct 26 04:09:48 EDT 2025 Tue Sep 30 15:40:25 EDT 2025 Fri Jul 11 09:43:52 EDT 2025 Thu Oct 02 06:02:44 EDT 2025 Thu Apr 03 07:01:06 EDT 2025 Tue Jul 01 03:25:14 EDT 2025 Thu Apr 24 23:05:28 EDT 2025 Wed Jan 17 02:37:36 EST 2024 Tue May 24 16:17:26 EDT 2022 Thu Jul 03 21:17:23 EDT 2025 Tue Sep 24 00:40:25 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1590 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c626t-dea4719331aa4217b071481f3b0ef255ddd2242d4b656b35048d2e29e4bcf0143 |
| Notes | One contribution of 14 to a Discussion Meeting Issue ‘Immunity, infection, migration and human evolution’. href:rstb20110266.pdf ArticleID:rstb20110266 istex:66E99459D34C131B72C8EFE2D708358F20E79A84 ark:/67375/V84-NFRWCSC0-W Discussion Meeting Issue 'Immunity, infection, migration and human evolution' organized and edited by Danny Altmann, Francois Balloux and Rosemary Boyton ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2011.0266 |
| PMID | 22312047 |
| PQID | 1008824712 |
| PQPubID | 23462 |
| PageCount | 12 |
| ParticipantIDs | royalsociety_journals_RSTBv367i1590_0831063045_zip_rstb_367_issue_1590_rstb_2011_0266_rstb_2011_0266 unpaywall_primary_10_1098_rstb_2011_0266 jstor_primary_41441733 proquest_miscellaneous_1008824712 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3267113 pubmed_primary_22312047 crossref_primary_10_1098_rstb_2011_0266 crossref_citationtrail_10_1098_rstb_2011_0266 istex_primary_ark_67375_V84_NFRWCSC0_W proquest_miscellaneous_920369760 royalsociety_journals_10_1098_rstb_2011_0266 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-03-19 20120319 2012-Mar-19 |
| PublicationDateYYYYMMDD | 2012-03-19 |
| PublicationDate_xml | – month: 3 year: 2012 text: 20120319 day: 19 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Philosophical transactions of the Royal Society of London. Series B. Biological sciences |
| PublicationTitleAbbrev | Phil. Trans. R. Soc. B |
| PublicationTitleAlternate | Phil. Trans. R. Soc. B |
| PublicationYear | 2012 |
| Publisher | The Royal Society |
| Publisher_xml | – name: The Royal Society |
| References | e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_87_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_85_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_68_2 e_1_3_2_24_2 e_1_3_2_66_2 e_1_3_2_89_2 e_1_3_2_60_2 e_1_3_2_83_2 e_1_3_2_81_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_75_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 Dohring C. (e_1_3_2_62_2) 1996; 156 e_1_3_2_73_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_79_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_77_2 e_1_3_2_92_2 e_1_3_2_50_2 e_1_3_2_71_2 e_1_3_2_90_2 Redman C. W. (e_1_3_2_86_2) 1984; 52 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_65_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_63_2 e_1_3_2_84_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_67_2 e_1_3_2_88_2 e_1_3_2_61_2 e_1_3_2_82_2 e_1_3_2_80_2 Winter C. C. (e_1_3_2_47_2) 1997; 158 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_76_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_74_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_78_2 e_1_3_2_2_2 e_1_3_2_91_2 e_1_3_2_72_2 e_1_3_2_70_2 Winter C. C. (e_1_3_2_69_2) 1998; 161 15632087 - Genome Res. 2005 Jan;15(1):25-35 21214544 - Immunology. 2011 Mar;132(3):315-25 9114037 - Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4604-9 11955593 - Mol Immunol. 2002 May;38(14):1007-21 21206914 - PLoS One. 2010;5(12):e15115 10781084 - Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83 19858347 - J Exp Med. 2009 Oct 26;206(11):2557-72 21614583 - Immunogenetics. 2011 Sep;63(9):577-85 20145268 - Haematologica. 2010 Aug;95(8):1381-8 19265140 - J Immunol. 2009 Mar 15;182(6):3618-27 21079681 - PLoS Genet. 2010 Nov;6(11):e1001192 9464792 - Eur J Immunol. 1997 Dec;27(12):3095-9 16533882 - J Exp Med. 2006 Mar 20;203(3):633-45 15194195 - Gene. 2004 Jun 23;335:121-31 20981092 - Nature. 2010 Oct 28;467(7319):1061-73 20147700 - Blood. 2010 Sep 9;116(10):1637-47 19837691 - Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18692-7 19828694 - Blood. 2009 Dec 10;114(25):5182-90 20972337 - J Clin Invest. 2010 Nov;120(11):4102-10 10894168 - Immunity. 2000 Jun;12(6):687-98 10190900 - J Exp Med. 1999 Apr 5;189(7):1093-100 15477349 - J Exp Med. 2004 Oct 18;200(8):957-65 21411368 - Trends Immunol. 2011 May;32(5):219-24 18635379 - Semin Immunol. 2008 Dec;20(6):343-52 12370253 - J Exp Med. 2002 Oct 7;196(7):911-21 19834558 - PLoS Genet. 2009 Oct;5(10):e1000688 16132082 - PLoS Genet. 2005 Aug;1(2):129-39 15297676 - Science. 2004 Aug 6;305(5685):872-4 20439706 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10160-5 9645365 - Eur J Immunol. 1998 Jun;28(6):1839-46 20026738 - J Immunol. 2010 Feb 1;184(3):1379-91 7931060 - J Exp Med. 1994 Oct 1;180(4):1235-42 21187902 - PLoS Genet. 2010 Dec;6(12):e1001249 11254692 - J Immunol. 2001 Apr 1;166(7):4380-90 18263639 - Hum Reprod. 2008 Apr;23(4):972-6 21106246 - Mol Immunol. 2011 Jan;48(4):553-62 20630802 - Trends Immunol. 2010 Aug;31(8):289-94 17450355 - Immunogenetics. 2007 Jun;59(6):517-22 11896281 - Science. 2002 Mar 15;295(5562):2097-100 19005473 - Genes Immun. 2009 Mar;10(2):162-73 16901727 - Immunity. 2006 Aug;25(2):331-42 16698429 - Hum Immunol. 2006 Jan-Feb;67(1-2):85-93 11870625 - Eur J Immunol. 2002 Mar;32(3):810-7 8617928 - J Immunol. 1996 May 1;156(9):3098-101 15162437 - Eur J Immunol. 2004 Jun;34(6):1673-9 18583565 - Blood. 2008 Sep 15;112(6):2369-80 20802150 - J Immunol. 2010 Oct 1;185(7):4233-7 9486650 - Nature. 1998 Feb 19;391(6669):795-9 16868549 - Nat Rev Immunol. 2006 Aug;6(8):584-94 15719024 - Nat Rev Immunol. 2005 Mar;5(3):201-14 12618911 - Immunogenetics. 2003 Feb;54(11):782-90 18945962 - Blood. 2009 Jan 15;113(3):726-32 9126959 - J Immunol. 1997 May 1;158(9):4026-8 9670929 - J Immunol. 1998 Jul 15;161(2):571-7 20483783 - J Immunol. 2010 Jun 1;184(11):6199-208 6204930 - Immunology. 1984 Jul;52(3):457-68 18595730 - Semin Immunol. 2008 Dec;20(6):321-30 17496894 - Nat Genet. 2007 Jun;39(6):733-40 12391228 - J Immunol. 2002 Nov 1;169(9):5118-29 9430221 - Immunity. 1997 Dec;7(6):753-63 2201309 - Immunol Today. 1990 Jul;11(7):237-44 21062830 - Nucleic Acids Res. 2011 Jan;39(Database issue):D913-9 12077248 - J Immunol. 2002 Jul 1;169(1):220-9 17202323 - J Immunol. 2007 Jan 15;178(2):647-51 20805421 - J Immunol. 2010 Oct 1;185(7):4238-51 9174606 - Eur J Immunol. 1997 May;27(5):1164-9 19265141 - J Immunol. 2009 Mar 15;182(6):3628-37 16911775 - BMC Genomics. 2006;7:209 21212348 - Science. 2011 Jan 7;331(6013):44-9 16738943 - Immunogenetics. 2006 Jun;58(5-6):474-80 2543925 - N Engl J Med. 1989 Jun 29;320(26):1731-5 11751968 - J Immunol. 2002 Jan 1;168(1):240-52 21690332 - J Immunol. 2011 Jul 1;187(1):11-9 15203220 - Genomics. 2004 Jul;84(1):218-21 17182537 - J Immunol. 2007 Jan 1;178(1):33-7 14688344 - J Immunol. 2004 Jan 1;172(1):356-69 21199942 - Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1022-7 19009288 - Immunogenetics. 2009 Jan;61(1):27-41 9126935 - J Exp Med. 1997 Apr 21;185(8):1523-8 15731175 - Blood. 2005 Jun 15;105(12):4878-84 19752231 - J Immunol. 2009 Oct 1;183(7):4569-82 16546094 - Immunity. 2006 Mar;24(3):249-57 9177214 - Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6313-8 20061017 - Placenta. 2010 Mar;31 Suppl:S87-92 19304956 - Blood. 2009 Jul 2;114(1):95-104 18977671 - Semin Immunol. 2008 Dec;20(6):369-75 17579070 - J Immunol. 2007 Jul 1;179(1):491-504 8476574 - Annu Rev Immunol. 1993;11:613-35 9826699 - Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14326-31 18941220 - J Immunol. 2008 Nov 1;181(9):6293-300 |
| References_xml | – ident: e_1_3_2_42_2 doi: 10.4049/jimmunol.0901734 – ident: e_1_3_2_39_2 doi: 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E – ident: e_1_3_2_14_2 doi: 10.4049/jimmunol.1000078 – volume: 156 start-page: 3098 year: 1996 ident: e_1_3_2_62_2 article-title: A human killer inhibitory receptor specific for HLA-A publication-title: J. Immunol. doi: 10.4049/jimmunol.156.9.3098 – ident: e_1_3_2_52_2 doi: 10.1093/nar/gkq1128 – ident: e_1_3_2_74_2 doi: 10.1016/j.it.2010.05.007 – ident: e_1_3_2_43_2 doi: 10.4049/jimmunol.178.1.33 – ident: e_1_3_2_64_2 doi: 10.4049/jimmunol.178.2.647 – ident: e_1_3_2_15_2 doi: 10.1146/annurev.iy.11.040193.003145 – ident: e_1_3_2_59_2 doi: 10.4049/jimmunol.0803401 – ident: e_1_3_2_20_2 doi: 10.4049/jimmunol.0803026 – ident: e_1_3_2_79_2 doi: 10.1016/j.smim.2008.06.003 – ident: e_1_3_2_11_2 doi: 10.1016/0167-5699(90)90097-S – ident: e_1_3_2_32_2 doi: 10.1002/1521-4141(200203)32:3<810::AID-IMMU810>3.0.CO;2-P – ident: e_1_3_2_66_2 doi: 10.1073/pnas.95.24.14326 – ident: e_1_3_2_72_2 doi: 10.1016/j.humimm.2005.11.007 – ident: e_1_3_2_73_2 doi: 10.1182/blood-2009-12-256586 – ident: e_1_3_2_9_2 doi: 10.1084/jem.20051884 – ident: e_1_3_2_35_2 doi: 10.1007/s00251-007-0214-x – ident: e_1_3_2_60_2 doi: 10.1111/j.1365-2567.2010.03398.x – ident: e_1_3_2_51_2 doi: 10.1073/pnas.94.12.6313 – ident: e_1_3_2_90_2 doi: 10.1126/science.1097670 – ident: e_1_3_2_22_2 doi: 10.4049/jimmunol.0903016 – ident: e_1_3_2_61_2 doi: 10.1016/j.gene.2004.03.018 – ident: e_1_3_2_24_2 doi: 10.1371/journal.pone.0015115 – ident: e_1_3_2_71_2 doi: 10.1007/s00251-006-0108-3 – ident: e_1_3_2_28_2 doi: 10.1016/j.smim.2008.09.007 – ident: e_1_3_2_29_2 doi: 10.4049/jimmunol.169.1.220 – ident: e_1_3_2_77_2 doi: 10.1182/blood-2009-07-231977 – ident: e_1_3_2_85_2 doi: 10.1016/j.placenta.2009.12.022 – ident: e_1_3_2_31_2 doi: 10.1016/S1074-7613(00)80219-8 – ident: e_1_3_2_33_2 doi: 10.4049/jimmunol.172.1.356 – ident: e_1_3_2_50_2 doi: 10.1084/jem.185.8.1523 – ident: e_1_3_2_5_2 doi: 10.1016/j.immuni.2006.06.013 – ident: e_1_3_2_13_2 doi: 10.4049/jimmunol.0902332 – ident: e_1_3_2_3_2 doi: 10.1126/science.1198687 – ident: e_1_3_2_92_2 doi: 10.1371/journal.pgen.1001249 – ident: e_1_3_2_88_2 doi: 10.1016/j.it.2011.02.003 – ident: e_1_3_2_48_2 doi: 10.4049/jimmunol.181.9.6293 – ident: e_1_3_2_75_2 doi: 10.1038/gene.2008.91 – ident: e_1_3_2_27_2 doi: 10.1007/s00251-002-0529-6 – ident: e_1_3_2_36_2 doi: 10.1186/1471-2164-7-209 – ident: e_1_3_2_37_2 doi: 10.1016/j.smim.2008.05.004 – ident: e_1_3_2_84_2 doi: 10.1172/JCI43998 – ident: e_1_3_2_6_2 doi: 10.1182/blood-2008-03-143727 – ident: e_1_3_2_2_2 doi: 10.1038/nri1570 – ident: e_1_3_2_40_2 doi: 10.1002/eji.1830270517 – ident: e_1_3_2_53_2 doi: 10.1182/blood-2008-07-171926 – ident: e_1_3_2_23_2 doi: 10.1007/s00251-008-0342-y – ident: e_1_3_2_68_2 doi: 10.1084/jem.189.7.1093 – ident: e_1_3_2_25_2 doi: 10.1101/gr.2381205 – ident: e_1_3_2_55_2 doi: 10.3324/haematol.2009.021121 – volume: 161 start-page: 571 year: 1998 ident: e_1_3_2_69_2 article-title: Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition publication-title: J. Immunol. doi: 10.4049/jimmunol.161.2.571 – ident: e_1_3_2_45_2 doi: 10.1016/S0161-5890(02)00030-5 – ident: e_1_3_2_10_2 doi: 10.1007/978-3-642-48287-8 – ident: e_1_3_2_65_2 doi: 10.1002/eji.1830271203 – ident: e_1_3_2_76_2 doi: 10.1073/pnas.0906051106 – ident: e_1_3_2_91_2 doi: 10.1038/ng2035 – ident: e_1_3_2_7_2 doi: 10.1182/blood-2008-10-184549 – ident: e_1_3_2_8_2 doi: 10.1016/j.immuni.2006.03.006 – ident: e_1_3_2_41_2 doi: 10.1073/pnas.0913745107 – ident: e_1_3_2_87_2 doi: 10.1073/pnas.1003865108 – ident: e_1_3_2_46_2 doi: 10.1016/j.molimm.2010.10.014 – volume: 158 start-page: 4026 year: 1997 ident: e_1_3_2_47_2 article-title: A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes publication-title: J. Immunol. doi: 10.4049/jimmunol.158.9.4026 – ident: e_1_3_2_80_2 doi: 10.1371/journal.pgen.1001192 – ident: e_1_3_2_21_2 doi: 10.1371/journal.pgen.1000688 – ident: e_1_3_2_44_2 doi: 10.1002/eji.200425089 – ident: e_1_3_2_58_2 doi: 10.1007/s00251-011-0535-7 – ident: e_1_3_2_63_2 doi: 10.1084/jem.180.4.1235 – ident: e_1_3_2_30_2 doi: 10.4049/jimmunol.166.7.4380 – ident: e_1_3_2_78_2 doi: 10.4049/jimmunol.169.9.5118 – ident: e_1_3_2_83_2 doi: 10.1084/jem.20041214 – ident: e_1_3_2_54_2 doi: 10.1182/blood-2004-12-4825 – ident: e_1_3_2_26_2 doi: 10.4049/jimmunol.179.1.491 – ident: e_1_3_2_38_2 doi: 10.1016/j.ygeno.2004.01.010 – ident: e_1_3_2_57_2 doi: 10.4049/jimmunol.1001494 – ident: e_1_3_2_12_2 doi: 10.1038/nature09534 – ident: e_1_3_2_19_2 doi: 10.4049/jimmunol.168.1.240 – ident: e_1_3_2_67_2 doi: 10.1084/jem.20091010 – ident: e_1_3_2_82_2 doi: 10.1093/humrep/den011 – ident: e_1_3_2_81_2 doi: 10.1084/jem.20020304 – ident: e_1_3_2_89_2 doi: 10.1056/NEJM198906293202605 – ident: e_1_3_2_4_2 doi: 10.1038/nri1897 – ident: e_1_3_2_18_2 doi: 10.1038/35869 – ident: e_1_3_2_16_2 doi: 10.1073/pnas.080588597 – ident: e_1_3_2_49_2 doi: 10.1073/pnas.94.9.4604 – volume: 52 start-page: 457 year: 1984 ident: e_1_3_2_86_2 article-title: Class I major histocompatibility complex antigens on human extra-villous trophoblast publication-title: Immunology – ident: e_1_3_2_17_2 doi: 10.1371/journal.pgen.0010027 – ident: e_1_3_2_56_2 doi: 10.1126/science.1068440 – ident: e_1_3_2_34_2 doi: 10.1016/S1074-7613(00)80394-5 – ident: e_1_3_2_70_2 doi: 10.4049/jimmunol.1001951 – reference: 8617928 - J Immunol. 1996 May 1;156(9):3098-101 – reference: 20802150 - J Immunol. 2010 Oct 1;185(7):4233-7 – reference: 8476574 - Annu Rev Immunol. 1993;11:613-35 – reference: 12370253 - J Exp Med. 2002 Oct 7;196(7):911-21 – reference: 10894168 - Immunity. 2000 Jun;12(6):687-98 – reference: 19265140 - J Immunol. 2009 Mar 15;182(6):3618-27 – reference: 12077248 - J Immunol. 2002 Jul 1;169(1):220-9 – reference: 20147700 - Blood. 2010 Sep 9;116(10):1637-47 – reference: 2201309 - Immunol Today. 1990 Jul;11(7):237-44 – reference: 20145268 - Haematologica. 2010 Aug;95(8):1381-8 – reference: 19752231 - J Immunol. 2009 Oct 1;183(7):4569-82 – reference: 9126959 - J Immunol. 1997 May 1;158(9):4026-8 – reference: 19005473 - Genes Immun. 2009 Mar;10(2):162-73 – reference: 9645365 - Eur J Immunol. 1998 Jun;28(6):1839-46 – reference: 16911775 - BMC Genomics. 2006;7:209 – reference: 20483783 - J Immunol. 2010 Jun 1;184(11):6199-208 – reference: 17579070 - J Immunol. 2007 Jul 1;179(1):491-504 – reference: 18941220 - J Immunol. 2008 Nov 1;181(9):6293-300 – reference: 19858347 - J Exp Med. 2009 Oct 26;206(11):2557-72 – reference: 20630802 - Trends Immunol. 2010 Aug;31(8):289-94 – reference: 9486650 - Nature. 1998 Feb 19;391(6669):795-9 – reference: 21212348 - Science. 2011 Jan 7;331(6013):44-9 – reference: 15632087 - Genome Res. 2005 Jan;15(1):25-35 – reference: 12391228 - J Immunol. 2002 Nov 1;169(9):5118-29 – reference: 7931060 - J Exp Med. 1994 Oct 1;180(4):1235-42 – reference: 10781084 - Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83 – reference: 21106246 - Mol Immunol. 2011 Jan;48(4):553-62 – reference: 19304956 - Blood. 2009 Jul 2;114(1):95-104 – reference: 9126935 - J Exp Med. 1997 Apr 21;185(8):1523-8 – reference: 18945962 - Blood. 2009 Jan 15;113(3):726-32 – reference: 21079681 - PLoS Genet. 2010 Nov;6(11):e1001192 – reference: 18595730 - Semin Immunol. 2008 Dec;20(6):321-30 – reference: 20439706 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10160-5 – reference: 6204930 - Immunology. 1984 Jul;52(3):457-68 – reference: 16868549 - Nat Rev Immunol. 2006 Aug;6(8):584-94 – reference: 10190900 - J Exp Med. 1999 Apr 5;189(7):1093-100 – reference: 18635379 - Semin Immunol. 2008 Dec;20(6):343-52 – reference: 21199942 - Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1022-7 – reference: 21411368 - Trends Immunol. 2011 May;32(5):219-24 – reference: 16546094 - Immunity. 2006 Mar;24(3):249-57 – reference: 18583565 - Blood. 2008 Sep 15;112(6):2369-80 – reference: 21187902 - PLoS Genet. 2010 Dec;6(12):e1001249 – reference: 9177214 - Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6313-8 – reference: 15731175 - Blood. 2005 Jun 15;105(12):4878-84 – reference: 17450355 - Immunogenetics. 2007 Jun;59(6):517-22 – reference: 19009288 - Immunogenetics. 2009 Jan;61(1):27-41 – reference: 16698429 - Hum Immunol. 2006 Jan-Feb;67(1-2):85-93 – reference: 20026738 - J Immunol. 2010 Feb 1;184(3):1379-91 – reference: 9670929 - J Immunol. 1998 Jul 15;161(2):571-7 – reference: 14688344 - J Immunol. 2004 Jan 1;172(1):356-69 – reference: 21206914 - PLoS One. 2010;5(12):e15115 – reference: 16738943 - Immunogenetics. 2006 Jun;58(5-6):474-80 – reference: 11955593 - Mol Immunol. 2002 May;38(14):1007-21 – reference: 2543925 - N Engl J Med. 1989 Jun 29;320(26):1731-5 – reference: 15162437 - Eur J Immunol. 2004 Jun;34(6):1673-9 – reference: 20805421 - J Immunol. 2010 Oct 1;185(7):4238-51 – reference: 21062830 - Nucleic Acids Res. 2011 Jan;39(Database issue):D913-9 – reference: 17496894 - Nat Genet. 2007 Jun;39(6):733-40 – reference: 9464792 - Eur J Immunol. 1997 Dec;27(12):3095-9 – reference: 16533882 - J Exp Med. 2006 Mar 20;203(3):633-45 – reference: 11254692 - J Immunol. 2001 Apr 1;166(7):4380-90 – reference: 21614583 - Immunogenetics. 2011 Sep;63(9):577-85 – reference: 18263639 - Hum Reprod. 2008 Apr;23(4):972-6 – reference: 20972337 - J Clin Invest. 2010 Nov;120(11):4102-10 – reference: 15194195 - Gene. 2004 Jun 23;335:121-31 – reference: 20061017 - Placenta. 2010 Mar;31 Suppl:S87-92 – reference: 18977671 - Semin Immunol. 2008 Dec;20(6):369-75 – reference: 17182537 - J Immunol. 2007 Jan 1;178(1):33-7 – reference: 21690332 - J Immunol. 2011 Jul 1;187(1):11-9 – reference: 11870625 - Eur J Immunol. 2002 Mar;32(3):810-7 – reference: 19834558 - PLoS Genet. 2009 Oct;5(10):e1000688 – reference: 9174606 - Eur J Immunol. 1997 May;27(5):1164-9 – reference: 15477349 - J Exp Med. 2004 Oct 18;200(8):957-65 – reference: 15297676 - Science. 2004 Aug 6;305(5685):872-4 – reference: 15719024 - Nat Rev Immunol. 2005 Mar;5(3):201-14 – reference: 19828694 - Blood. 2009 Dec 10;114(25):5182-90 – reference: 19837691 - Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18692-7 – reference: 16901727 - Immunity. 2006 Aug;25(2):331-42 – reference: 11896281 - Science. 2002 Mar 15;295(5562):2097-100 – reference: 19265141 - J Immunol. 2009 Mar 15;182(6):3628-37 – reference: 12618911 - Immunogenetics. 2003 Feb;54(11):782-90 – reference: 15203220 - Genomics. 2004 Jul;84(1):218-21 – reference: 17202323 - J Immunol. 2007 Jan 15;178(2):647-51 – reference: 9430221 - Immunity. 1997 Dec;7(6):753-63 – reference: 9114037 - Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4604-9 – reference: 9826699 - Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14326-31 – reference: 11751968 - J Immunol. 2002 Jan 1;168(1):240-52 – reference: 21214544 - Immunology. 2011 Mar;132(3):315-25 – reference: 16132082 - PLoS Genet. 2005 Aug;1(2):129-39 – reference: 20981092 - Nature. 2010 Oct 28;467(7319):1061-73 |
| SSID | ssj0009574 |
| Score | 2.4619343 |
| SecondaryResourceType | review_article |
| Snippet | In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions... |
| SourceID | unpaywall pubmedcentral proquest pubmed crossref royalsociety jstor istex |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 800 |
| SubjectTerms | Animals Balancing Selection Epitopes Evolution Evolution, Molecular Genetics, Population Haplotypes Haplotypes - genetics Histocompatibility Antigens Class I - metabolism HLA antigens HLA C antigens Humans Ligands Major Histocompatibility Complex Models, Molecular Natural Killer Cells Pan troglodytes Primates Primates - genetics Primates - immunology Receptors Receptors, KIR - genetics Receptors, KIR - metabolism Review Species Specificity T lymphocytes |
| Title | Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules |
| URI | https://api.istex.fr/ark:/67375/V84-NFRWCSC0-W/fulltext.pdf https://www.jstor.org/stable/41441733 https://royalsocietypublishing.org/doi/full/10.1098/rstb.2011.0266 https://www.ncbi.nlm.nih.gov/pubmed/22312047 https://www.proquest.com/docview/1008824712 https://www.proquest.com/docview/920369760 https://pubmed.ncbi.nlm.nih.gov/PMC3267113 https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2011.0266 |
| UnpaywallVersion | publishedVersion |
| Volume | 367 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2970 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009574 issn: 1471-2970 databaseCode: KQ8 dateStart: 18870101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2970 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009574 issn: 1471-2970 databaseCode: KQ8 dateStart: 19970101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1471-2970 dateEnd: 20241105 omitProxy: true ssIdentifier: ssj0009574 issn: 1471-2970 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-2970 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009574 issn: 1471-2970 databaseCode: GX1 dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1471-2970 dateEnd: 20241105 omitProxy: true ssIdentifier: ssj0009574 issn: 1471-2970 databaseCode: RPM dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tb9MwED5BK5j4AKwwCILJSAiGRCAvbpN8HBXVBqJC28rgkxUnjlbapVFfxrofwO_mzk6jdrQCia_N1XHP5_Nd77nHAC8oSfY9mdlcptzmLo_tSErMUnislCMTqr0R2qLbOujxj9-aCzQh9cKMKWmeGMBiUf0Ro0v6tMeLNCs5kMJ3GB3JkoMTT5mbUG81MRyvQb3X_bL_XXPstXC3c990GAWu7UWBUxE3Xh9g5WCqk44vFxjFddHnGhDl8tzvwNYsL-L5z3g4XDqwOvdALn6qwakM3s5wFsnVNRbI_9LFfbhbhrNs39jfNtxQeQNumQsu5w24_bks3Tdgu_QiE7ZXUl2_fgC_dA3BpnZPgiwxdVHuBDbK2EC3KTIqLbA-tbGMiL2EkPP2sD9QDH21KlBvrAJBme-dxz_wQ02krBH2UwMAnjMNn1eXLKGMgR2yc3M1sJo8hF7nw0n7wC5vhrATTMCmdqpiXE80MzeOOSZVktqwQjfzpaMyTJLSNMXQxEu5xHBV-k10U6mnvEhxmWTEaLgDtXyUq8fAuIpSHkvXCVXEE0eGYULdvDJEzybDyLXAXpiFSEradLq9YyhM-T4UpHtBuhekewteVfKFIQzZKPlSW1klFo8HBLMLmuJryEW3c3TaPm474tSCHW2GlSCnLDjwfQueL-xSoFeg9YhzNZpNiIkaUyfUkWcB2yATUQ0ao1HHgkfGlKsXYMzoeg4PLAhWjLwSIFLy1Sd5_0yTk2M6ELguTu3NsvmK0jNONuoiXS9-dHzy_sJvBX0Mux2hr8VrUXFfXPULMwY-FNpHCS2yOu4fr9mrduVfVufJv4s-hdp0PFPPMDqdyl3Myw4_7ZZe6Dd9PJFS |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tb9MwED5BK0B8AFYYBAEyEoIhEciL2yQfR0U1kKjQtjL2yYoTR4R2adSXse4H8Lu5s9OoHa1A4mtzddzz-XzXe-4xwAtKkn1PZjaXKbe5y2M7khKzFB4r5ciEam-Etuh3Dgb807f2Ek1IvTATSpqnBrBY1n_E6JI-7fEyzSoOpPAdRkey4uDEU-Y6NDttDMcb0Bz0v-yfao69Du527psOo8C1vShwauLGqwOsHUxN0vHFEqO4KfrcAKJcnfttuDUvynjxMx6NVg6s3l2Qy59qcCrDt3OcRXJ5hQXyv3RxD-5U4SzbN_a3A9dU0YIb5oLLRQtufq5K9y3YqbzIlO1VVNev78MvXUOwqd2TIEtMnVc7gY0zNtRtioxKCyynNpYxsZcQct4e5UPF0FerEvXGahCU-d5Z_AM_1ETKGmE_MwDgBdPweXXBEsoY2Ed2Zq4GVtMHMOh9OO4e2NXNEHaCCdjMTlWM64lm5sYxx6RKUhtW6Ga-dFSGSVKaphiaeCmXGK5Kv41uKvWUFykuk4wYDXehUYwL9QgYV1HKY-k6oYp44sgwTKibV4bo2WQYuRbYS7MQSUWbTrd3jIQp34eCdC9I94J0b8GrWr40hCFbJV9qK6vF4smQYHZBW3wNuej3Dk-6R11HnFiwq82wFuSUBQe-b8HzpV0K9Aq0HnGhxvMpMVFj6oQ68ixgW2QiqkFjNOpY8NCYcv0CjBldz-GBBcGakdcCREq-_qTIv2tyckwHAtfFqb1ZNV9RecbpVl2km8UPj47fn_udIMew2xH6WrwOFffFZV6aMfCh0D5KaJH1cf94zV69K_-yOo__XfQJNGaTuXqK0elMPqv8z28a6JBZ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human-specific+evolution+of+killer+cell+immunoglobulin-like+receptor+recognition+of+major+histocompatibility+complex+class+I+molecules&rft.jtitle=Philosophical+transactions+of+the+Royal+Society+of+London.+Series+B.+Biological+sciences&rft.au=Parham%2C+Peter&rft.au=Norman%2C+Paul+J.&rft.au=Abi-Rached%2C+Laurent&rft.au=Guethlein%2C+Lisbeth+A.&rft.date=2012-03-19&rft.issn=0962-8436&rft.eissn=1471-2970&rft.volume=367&rft.issue=1590&rft.spage=800&rft.epage=811&rft_id=info:doi/10.1098%2Frstb.2011.0266&rft.externalDBID=n%2Fa&rft.externalDocID=10_1098_rstb_2011_0266 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-8436&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-8436&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-8436&client=summon |